Sale disclosed
Peter Greenleaf
Director
Common Stock
- Reported value
- $16.87K
- Reported price
- $21.17 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Pelthos Therapeutics Inc.
Last 30 daysNo qualifying insider buying. Sales: $44.94K by 3 insiders.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
Director
Common Stock
$249,996 of common-equity purchase value after transaction-age decay across 180 days.
1 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
CFO, Treas & Secty
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
CFO, Treas & Secty
Common Stock
CFO, Treas & Secty
Stock Option
Derivative security · not the ordinary share price.
CFO, Treas & Secty
Stock Option
Derivative security · not the ordinary share price.
Director
Common Stock
Director
Common Stock
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockSale10b5-1 | 797$21.17 / share | $16.87K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Director | Common StockSale10b5-1 | 558$20.72 / share | $11.56K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Director | Common StockSale10b5-1 | 786$21.00 / share | $16.51K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 558avg $26.09 / share | $14.56K | Jul 2Filed Jul 7 · 5d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 786avg $26.16 / share | $20.56K | Jul 2Filed Jul 7 · 5d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 797avg $26.13 / share | $20.83K | Jul 2Filed Jul 7 · 5d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 283avg $27.29 / share | $7.72K | Jun 15Filed Jun 17 · 2d later | 2 filings
|
| Director | Common StockPurchase2 trades | 35,948avg $27.82 / share | $999.98K | Jun 11Filed Jun 15 · 4d later | 2 filings
|
| CFO, Treas & Secty | Common StockDisposition to issuer | 13,947$0 reported · see filing | Not established | May 22Filed May 26 · 4d later | SEC filing |
| CFO, Treas & Secty | Common StockSale | 1,500$26.84 / share | $40.26K | May 22Filed May 26 · 4d later | SEC filing |
| CFO, Treas & Secty | Stock OptionGrant or award | Derivative units59,500Price not reported | Unavailable | May 22Filed May 26 · 4d later | SEC filing |
| CFO, Treas & Secty | Stock OptionDisposition to issuer | Derivative units42,500Price not reported | Unavailable | May 22Filed May 26 · 4d later | SEC filing |
| Director | Common StockExercise-price or tax withholding10b5-1 | 144$27.01 / share | $3.89K | May 14Filed May 18 · 4d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 590avg $20.92 / share | $12.34K | Apr 2Filed Apr 6 · 4d later | 2 filings
|
Showing the latest 20 of 41 trades. Show all 41 trades
This reflects the filings imported so far, not a complete trading history.